Skip Navigation

Rheumatology 2005 44(11):1373; doi:10.1093/rheumatology/kei158
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Limmroth, V.
Right arrow Articles by Wanke, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limmroth, V.
Right arrow Articles by Wanke, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

CLINICAL VIGNETTE

Cerebral MRI is necessary in patients with rheumatoid arthritis and uveitis before undergoing therapy with TNF-{alpha} blocking agents

V. Limmroth, C. Thimm, T. Hudde, T. Fuchsluger and I. Wanke

Correspondence to: V. Limmroth. E-mail: Volker.Limmroth@uni-essen.de

The first 10% of the full text of this article appears below.

Optic neuritis (ON) is often the first symptom of further demyelinating events within the central nervous system (CNS), eventually developing into multiple sclerosis (MS). As for rheumatoid arthritis (RA), . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?